Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.conduitpharma.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

Bullish_Bearish88 Mar. 20 at 2:15 PM

$CDT ready to short again Bring on the R/S😂

0 · Reply

ClearBlueWaters Mar. 16 at 11:40 PM

$CDT https://www.cstproxy.com/cdtequity/2026

0 · Reply

topstockalerts Mar. 13 at 9:45 PM

After Hours Top Gainers PT2 $CDT $AURE $CVKD $RBNE $TURB

0 · Reply

ka1954 Mar. 13 at 7:57 PM

$CDT piece of crap. another 20% cut. useless stock

0 · Reply

Sam201 Mar. 13 at 7:21 PM

$CDT another 2k shares. 15k. Final Vote on Monday so this complete shakeup

2 · Reply

DORO879 Mar. 13 at 9:05 AM

$CDT vote what you choice ?

0 · Reply

DARKP00L Mar. 12 at 12:47 PM

$CDT 08:40 on Mar. 12 2026 CDT Equity Announces Sarborg Expands Its AI Signature Agent Platform Through Curation Of Rare Disease Signature Database #tradeideas

0 · Reply

ClearBlueWaters Mar. 12 at 12:39 PM

$CDT https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl163203.pdf

0 · Reply

Sam201 Mar. 11 at 2:36 PM

$CDT another 3k to 13k shares! This one is very risky n load knowing you may lose significantly. On the plus side- tiny float!

0 · Reply

Jeffartist Mar. 11 at 9:57 AM

$AMFN $IXHL $CDT $OPEN

0 · Reply

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

Mar 12, 2026, 8:30 AM EDT - 9 days ago

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

Mar 5, 2026, 8:30 AM EST - 16 days ago

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

Mar 4, 2026, 8:30 AM EST - 17 days ago

CDT Positions for Transformational Growth

Feb 24, 2026, 8:30 AM EST - 25 days ago

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

Feb 20, 2026, 8:30 AM EST - 4 weeks ago

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

Jan 2, 2026, 8:30 AM EST - 2 months ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 5 months ago

CDT Equity Increases Bitcoin Holding

Oct 9, 2025, 8:00 AM EDT - 5 months ago

CDT Equity Inc. Announces Reverse Stock Split

Sep 17, 2025, 8:30 AM EDT - 6 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 7 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 8 months ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 9 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Bullish_Bearish88 Mar. 20 at 2:15 PM

$CDT ready to short again Bring on the R/S😂

0 · Reply

ClearBlueWaters Mar. 16 at 11:40 PM

$CDT https://www.cstproxy.com/cdtequity/2026

0 · Reply

topstockalerts Mar. 13 at 9:45 PM

After Hours Top Gainers PT2 $CDT $AURE $CVKD $RBNE $TURB

0 · Reply

ka1954 Mar. 13 at 7:57 PM

$CDT piece of crap. another 20% cut. useless stock

0 · Reply

Sam201 Mar. 13 at 7:21 PM

$CDT another 2k shares. 15k. Final Vote on Monday so this complete shakeup

2 · Reply

DORO879 Mar. 13 at 9:05 AM

$CDT vote what you choice ?

0 · Reply

DARKP00L Mar. 12 at 12:47 PM

$CDT 08:40 on Mar. 12 2026 CDT Equity Announces Sarborg Expands Its AI Signature Agent Platform Through Curation Of Rare Disease Signature Database #tradeideas

0 · Reply

ClearBlueWaters Mar. 12 at 12:39 PM

$CDT https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl163203.pdf

0 · Reply

Sam201 Mar. 11 at 2:36 PM

$CDT another 3k to 13k shares! This one is very risky n load knowing you may lose significantly. On the plus side- tiny float!

0 · Reply

Jeffartist Mar. 11 at 9:57 AM

$AMFN $IXHL $CDT $OPEN

0 · Reply

Jeffartist Mar. 11 at 1:11 AM

$AMFN $IXHL $CDT $OPEN

0 · Reply

silentsparrow Mar. 10 at 11:30 PM

$AMFN hooking up a fusion device to power a city in 2026!!! Thats insane. 1st of its kind tech!!! LFGOOOO. Plenty of dd on the page! Im not asking you to buy a million shares. Just look into it $IXHL $CDT $OPEN Come on open army lets make a fusion army and get ticher than wolf of walstreet himself!!!

2 · Reply

falcon630 Mar. 10 at 5:07 PM

$CDT another rs and more dilution to follow. I promise you..

1 · Reply

vmkhc Mar. 6 at 9:15 PM

$CDT RS Vote March 17 2026 https://www.sec.gov/Archives/edgar/data/1896212/000149315226009143/formdef14a.htm

0 · Reply

Nevilhch Mar. 4 at 11:28 PM

$CDT Every time this company says in a press conference that it wants to generate value for the shareholder... 😂😅😂😅😂 get ready, it's going to hell, like there's no tomorrow jeje

0 · Reply

Bullish_Bearish88 Mar. 4 at 9:21 PM

$CDT still garbage and will always be garbage . They will R/S again and they got millions of shares to dump.

0 · Reply

BrokeBoiTrading Feb. 28 at 12:04 AM

$CDT another split? jesus thank god i left this about two splits ago holy. i suffered the first one, so this is number 4 in less than a year.

1 · Reply

BrokeBoiTrading Feb. 28 at 12:03 AM

$CDT Why is Andrew Regan still making deals with himself? He is also the director of Sarborg, is that not conflict of interest?

0 · Reply

Nevilhch Feb. 25 at 5:24 PM

$CDT Every week you check their page, 1 million more shares appear that have been diluted.

0 · Reply

Nevilhch Feb. 25 at 12:07 PM

$CDT And now eToro won't let me short this crap... honestly, it's the worst stock on the market🤨🤨🤨🤦

2 · Reply

ClearBlueWaters Feb. 24 at 10:24 PM

$CDT https://capedge.com/filing/1896212/0001493152-26-007906/CDT-8K

1 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A